Choksi Laboratories Ltd Share Price Today - Choksi Laboratories Ltd Stock Price Live NSE/BSE

Choksi Laboratories Ltd

NSE: BSE: 526546

₹101.95

(2.88%)

Tue, 05 May 2026, 09:05 pm

MTF 5xInvest in Choksi Laboratories Ltd with 5x Leverage Buy with MTF

Market Cap693.04M

PE Ratio38.20

Dividend0

Commercial Services

Miscellaneous Commercial Services

24.5K

Choksi Laboratories Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
70.14
Net Profit
1.52
P/B
3.55
Sector P/E
77.77
P/E
54.86
EV/EBITDA
9.87
Debt/Equity (Industry)
0.58
Interest Cover (Industry)
3.72
ROCE (Industry)
6.51
RONW (Industry)
5.73
ROE
6.63
ROCE
8.89
Debt/Equity
1.31
EPS (TTM)
2.29
Dividend Yield
0
Book Value
35.17
Interest Cover
1.79

Analysis

all

Pros

Choksi Laboratories is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Choksi Laboratories has been profitable on average in the past, therefore cash runway is not a concern.
Choksi Laboratories has been profitable on average in the past, therefore cash runway is not a concern.
Debt is well covered by operating cash flow (30.8%, greater than 20% of total debt).
The average tenure for the Choksi Laboratories board of directors is over 10 years, this suggests they are a seasoned and experienced board.

Cons

Unable to evaluate Choksi Laboratories's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Choksi Laboratories's dividend against the top 25% market benchmark as the company has not reported any payouts.
Debt is not covered by short term assets, assets are 0.7x debt.
Choksi Laboratories's long term commitments exceed its cash and other short term assets.
The level of debt compared to net worth has increased over the past 5 years (44% vs 97.7% today).

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	31.48	31.48	31.48	31.48	31.48
FII	6.03	5.69	5.69	4.31	1.94
DII	0	0	0	0	0
Public	62.49	62.83	62.83	64.21	66.58
Government	0	0	0	0	0

Technical Analysis

RSI

48.95

MACD

-0.58

50 DMA

102.65

200 DMA

144.87

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	151.38	126.78	114.37	102.18	89.77	77.58	52.98
Fibonacci	126.78	117.39	111.58	102.18	92.79	86.98	77.58
Camarilla	108.72	106.46	104.20	102.18	99.70	97.44	95.19

Pivots Level: Classic

+49.20

151.38

+24.60

126.78

+12.18

114.37

102.18

Pivot Point

LTP: 101.10

-12.42

89.77

-24.60

77.58

-49.20

52.98

Moving Average

SMAEMA

Period

Value

10-EMA
101.22
20-EMA
101.51
30-EMA
102.17
50-EMA
104.66
100-EMA
113.98
200-EMA
124.55

Announcement Date	Purpose	Action
07 Feb 2026	board-meetings	Quarterly Results, Change in Directors
14 Nov 2025	board-meetings	Quarterly Results, Half Yearly Results
22 Aug 2025	agm
14 Aug 2024	agm
14 Aug 2023	agm
13 Aug 2022	agm
13 Aug 2021	agm

Choksi Laboratories Ltd

Narayana Hrudayalaya Ltd

Aster DM Healthcare Ltd

Apollo Hospitals Enterprise Ltd

Max Healthcare Institute Ltd

Fortis Healthcare Ltd

Choksi Laboratories Ltd About

Choksi Laboratories is engaged in the sole segment of Analysis and Testing.

Industry

Miscellaneous

Founded

1993

Headquarters

CEO

Sunil Choksi

Employees

Contact

Website

http://www.choksilab.com

compliance_officer@choksilab.com, indore@choksilab

Phone

Location

Survey no 9/1 Gram Kumerdi, Near to Tulshiyana Indl Park, Indore, Madhya Pradesh, 452010

Year	History
1982	The promoters of the Company established partnership and proprietary firms in the testing and analysis business.
1993	The Company was incorporated with the main object to act as analyser and examiner of pharmaceuticals, medicines, and drugs, and to provide testing facilities for various items.
2014	The Board approved the incorporation of a wholly owned foreign subsidiary of the Company in the United States of America.

Client Name	Order Side	QTY	Avg Price	Date
ESSENCE DEALMARK PRIVATE LIMITED	Sell	40457	142.28	06 Nov 2025
NEXUS GLOBAL OPPORTUNITIES FUND	Buy	50000	215	13 Aug 2025
NEXUS GLOBAL OPPORTUNITIES FUND	Buy	40000	197.95	01 Jul 2025
NEXUS GLOBAL OPPORTUNITIES FUND	Buy	50000	130	04 Jun 2025
LOVLESH JAIN	Sell	54451	130.02	04 Jun 2025
PSR WEALTH ADVISORS LLP	Sell	44776	118	07 May 2025
ALANKIT IMAGINATIONS LIMITED	Buy	44500	118	07 May 2025
ALANKIT IMAGINATIONS LIMITED	Buy	40000	121.81	06 May 2025
PARDEEP KUMAR AGGARWAL	Sell	71000	121.28	06 May 2025
NEXUS GLOBAL OPPORTUNITIES FUND	Buy	40000	120.82	06 May 2025

Choksi Laboratories Ltd News

Choksi Labs Gets 99.86% Approval for Director Appointment

Choksi Laboratories Limited completed postal ballot on April 26, 2026, with shareholders approving Mr. Ritik Pavecha's appointment as Non-Executive Independent Director with 99.86% votes in favor.

28 Apr 2026

companies

Choksi Labs confirms non-applicability of SEBI debt rules

Choksi Laboratories confirms it doesn't fall under 'Large Corporate' category, exempting it from SEBI's debt securities framework requirements for FY26.

15 Apr 2026

companies

Choksi Labs Submits Q4FY26 Compliance Certificate

Choksi Laboratories Limited submitted its compliance certificate under SEBI Regulation 74(5) for Q4FY26, confirming proper dematerialisation processes through registrar MUFG Intime India.

07 Apr 2026

companies

Choksi Labs Publishes Postal Ballot Notice in Newspapers

Choksi Laboratories Limited published postal ballot notice confirmation in Free Press Journal English and Choutha Sansar Hindi editions on March 27, 2026, regarding director appointment e-voting process.

27 Mar 2026

companies

Choksi Labs Postal Ballot for Director Appointment

Choksi Laboratories announces postal ballot notice dated February 7, 2026 for e-voting on appointment of Mr. Ritik Pavecha as Non-Executive Independent Director, with voting period from March 28 to April 26, 2026.

26 Mar 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800